FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273897605> ?p ?o ?g. }

• W2273897605 endingPage "91" @default.
• W2273897605 startingPage "587" @default.
• W2273897605 abstract "To explore the impact of courses of intermediate-dose cytarabine (ID-Ara-C) chemotherapy on the efficiency of hematopoietic stem cell mobilization in acute myeloid leukemia (AML) patients with autologous hematopoietic stem cell transplantation (auto-HSCT).90 patients with de novo AML undergoing auto-HSCT between August 1999 and November 2012 were enrolled. All patients received the mobilization regimen of cytarabine and etoposide chemotherapy in combination with recombinant human granulocyte-colony stimulating factor (rhG-CSF). Stem cell apheresis was scheduled when blood leukocyte count recovered greater than 4.0 × 10⁹/L or the proportion of CD34⁺ cells greater than 1% in peripheral blood. The impact of ID-Ara-C courses on the mobilization efficiency was analyzed retrospectively.According to the ID-Ara-C courses, patients were divided into group A (<2 courses), B (2 courses), and C (>2 courses). The median doses of CD34⁺ cells (×10⁶/kg) in three groups were 4.7, 2.7, 2.3, respectively (P=0.003). Of the available 87 patients who could be evaluated, 61 (70.1%) cases had CD34⁺ cells greater than 2.0 × 10⁶/kg, and 26 (29.9%) cases less than 2.0 × 10⁶/kg. Of the 26 patients without satisfactory mobilization efficiency, 7 (15.2%) were in group A, 10 (47.6%) in group B, and 9 (45.0%) in group C (χ²=10.05, P=0.007). In addition, patients with satisfactory mobilization efficiency (CD34⁺ cells ≥ 2.0×10⁶/kg) in groups C needed more times of collection, more volume of blood processed, and even high-dose and longer course of rhG-CSF (P<0.05). In univariate analysis. The ID-Ara-C courses and the cumulative dose were significant correlate with mobilization efficiency. In multivariate analysis, the ID-Ara-C courses was an independent correlation factor for mobilization efficiency (odd ratio=0.623, 95% confidence interval=0.418-0.926, P=0.019). The sex, age, cytogenetic risk, the standard chemotherapy courses did not correlate with mobilization efficiency.The number of ID-Ara-C courses was independent factor for the mobilization efficiency and should be taken seriously in AML patients with auto-HSCT." @default.
• W2273897605 created "2016-06-24" @default.
• W2273897605 creator A5003552301 @default.
• W2273897605 creator A5010298865 @default.
• W2273897605 creator A5027960395 @default.
• W2273897605 creator A5032457247 @default.
• W2273897605 creator A5036304210 @default.
• W2273897605 creator A5040721399 @default.
• W2273897605 creator A5041183580 @default.
• W2273897605 creator A5047380175 @default.
• W2273897605 creator A5053447705 @default.
• W2273897605 creator A5067670661 @default.
• W2273897605 creator A5071773009 @default.
• W2273897605 creator A5082138222 @default.
• W2273897605 date "2014-07-01" @default.
• W2273897605 modified "2023-10-16" @default.
• W2273897605 title "[Effect of intermediate-dose cytarabine on mobilization of peripheral blood hematopoietic stem cell in acute myeloid leukemia]." @default.
• W2273897605 doi "https://doi.org/10.3760/cma.j.issn.0253-2727.2014.07.003" @default.
• W2273897605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25052597" @default.
• W2273897605 hasPublicationYear "2014" @default.
• W2273897605 type Work @default.
• W2273897605 sameAs 2273897605 @default.
• W2273897605 citedByCount "0" @default.
• W2273897605 crossrefType "journal-article" @default.
• W2273897605 hasAuthorship W2273897605A5003552301 @default.
• W2273897605 hasAuthorship W2273897605A5010298865 @default.
• W2273897605 hasAuthorship W2273897605A5027960395 @default.
• W2273897605 hasAuthorship W2273897605A5032457247 @default.
• W2273897605 hasAuthorship W2273897605A5036304210 @default.
• W2273897605 hasAuthorship W2273897605A5040721399 @default.
• W2273897605 hasAuthorship W2273897605A5041183580 @default.
• W2273897605 hasAuthorship W2273897605A5047380175 @default.
• W2273897605 hasAuthorship W2273897605A5053447705 @default.
• W2273897605 hasAuthorship W2273897605A5067670661 @default.
• W2273897605 hasAuthorship W2273897605A5071773009 @default.
• W2273897605 hasAuthorship W2273897605A5082138222 @default.
• W2273897605 hasConcept C10205521 @default.
• W2273897605 hasConcept C109159458 @default.
• W2273897605 hasConcept C126322002 @default.
• W2273897605 hasConcept C129470790 @default.
• W2273897605 hasConcept C13373296 @default.
• W2273897605 hasConcept C143998085 @default.
• W2273897605 hasConcept C156708679 @default.
• W2273897605 hasConcept C166957645 @default.
• W2273897605 hasConcept C170493617 @default.
• W2273897605 hasConcept C2776694085 @default.
• W2273897605 hasConcept C2776738589 @default.
• W2273897605 hasConcept C2777408962 @default.
• W2273897605 hasConcept C2777767877 @default.
• W2273897605 hasConcept C2778041864 @default.
• W2273897605 hasConcept C2778119113 @default.
• W2273897605 hasConcept C2778461978 @default.
• W2273897605 hasConcept C2778729363 @default.
• W2273897605 hasConcept C2778828106 @default.
• W2273897605 hasConcept C2779282312 @default.
• W2273897605 hasConcept C28328180 @default.
• W2273897605 hasConcept C2911091166 @default.
• W2273897605 hasConcept C54355233 @default.
• W2273897605 hasConcept C71924100 @default.
• W2273897605 hasConcept C86803240 @default.
• W2273897605 hasConcept C89560881 @default.
• W2273897605 hasConcept C90924648 @default.
• W2273897605 hasConcept C95457728 @default.
• W2273897605 hasConceptScore W2273897605C10205521 @default.
• W2273897605 hasConceptScore W2273897605C109159458 @default.
• W2273897605 hasConceptScore W2273897605C126322002 @default.
• W2273897605 hasConceptScore W2273897605C129470790 @default.
• W2273897605 hasConceptScore W2273897605C13373296 @default.
• W2273897605 hasConceptScore W2273897605C143998085 @default.
• W2273897605 hasConceptScore W2273897605C156708679 @default.
• W2273897605 hasConceptScore W2273897605C166957645 @default.
• W2273897605 hasConceptScore W2273897605C170493617 @default.
• W2273897605 hasConceptScore W2273897605C2776694085 @default.
• W2273897605 hasConceptScore W2273897605C2776738589 @default.
• W2273897605 hasConceptScore W2273897605C2777408962 @default.
• W2273897605 hasConceptScore W2273897605C2777767877 @default.
• W2273897605 hasConceptScore W2273897605C2778041864 @default.
• W2273897605 hasConceptScore W2273897605C2778119113 @default.
• W2273897605 hasConceptScore W2273897605C2778461978 @default.
• W2273897605 hasConceptScore W2273897605C2778729363 @default.
• W2273897605 hasConceptScore W2273897605C2778828106 @default.
• W2273897605 hasConceptScore W2273897605C2779282312 @default.
• W2273897605 hasConceptScore W2273897605C28328180 @default.
• W2273897605 hasConceptScore W2273897605C2911091166 @default.
• W2273897605 hasConceptScore W2273897605C54355233 @default.
• W2273897605 hasConceptScore W2273897605C71924100 @default.
• W2273897605 hasConceptScore W2273897605C86803240 @default.
• W2273897605 hasConceptScore W2273897605C89560881 @default.
• W2273897605 hasConceptScore W2273897605C90924648 @default.
• W2273897605 hasConceptScore W2273897605C95457728 @default.
• W2273897605 hasIssue "7" @default.
• W2273897605 hasLocation W22738976051 @default.
• W2273897605 hasOpenAccess W2273897605 @default.
• W2273897605 hasPrimaryLocation W22738976051 @default.
• W2273897605 hasRelatedWork W1994163509 @default.
• W2273897605 hasRelatedWork W2022220426 @default.
• W2273897605 hasRelatedWork W2046286926 @default.
• W2273897605 hasRelatedWork W2048294528 @default.

• next